Clinical trials
Recruiting Phase 1/2 trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
153 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 15 |
| 2022 | 14 |
| 2023 | 21 |
| 2024 | 29 |
| 2025 | 37 |
| 2026 | 22 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 153 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 11 |
| AstraZeneca | 9 |
| Bristol-Myers Squibb | 6 |
| GlaxoSmithKline | 6 |
| Novartis Pharmaceuticals | 5 |
| Arrowhead Pharmaceuticals | 3 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 3 |
| Janssen Research & Development, LLC | 3 |
| Kriya Therapeutics, Inc. | 3 |
| ModernaTX, Inc. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 13 |
| Breast Neoplasms | 11 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Colorectal Neoplasms | 11 |
| Lung Neoplasms | 9 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 |
| Neoplasm Metastasis | 7 |
| Endometrial Neoplasms | 6 |
| Multiple Myeloma | 6 |
| Ovarian Neoplasms | 5 |
Trials
Showing 1 to 25 of 153. Each trial links to its page on Pharma Observatory.
53 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.